Cubresa Featured in IEEE Poster in South Korea
15 November 2013 - Andrew Goertzen, advisor to Cubresa, presented a poster at the IEEE Nuclear Science Symposium, Medical Imaging Conference and Real Time Semiconductor Detector Workshop in Seoul, Korea. This poster outlines the performance characteristics of a Cubresa handheld camera which is being developed for use in surgery.
Cubresa Moves to Larger Premises
21 September 2013 - Cubresa is pleased to announce that we have moved to larger office and manufacturing space at 1393 Border Street in Winnipeg. This increased space is a testament to our advancing relationship with our customers and the investment that we are receiving from our community.
Cubresa Receives Investment
27 June 2013 - Cubresa is pleased to announce that we have received investment from the Manitoba Knights. This $500,000 Series A investment will be used to support first revenue activities from our surgical oncology and preclinical marketplaces.
Cubresa Innovative Company Award from LSAM
14 February 2013 - Cubresa is pleased to accept the Innovative Medical Company of the Year Award from 2012 from LSAM. The award was presented to our Founder and CEO James Schellenberg at the LSAM gala dinner Wednesday night. James was joined at the dinner by Cubresa team members Bob Schellenberg, Michael Simpson, Mike Pilon, Svetlana Artemchuk, Cheryl Dika, Lisa Bako and John Saunders, and received the award on all of our behalf. Additional information on the award is available from the LSAM website.
Advance Product Release for MRG1502
19 November 2012 - Cubresa is pleased to announce the advance product release of the MRG1502 system. The MRG1502 is suitable for fixed radioisotope distributions, and uses an MR Conditional Gamma Camera Head GCH1501, an Interface Module IFM808, and Core software running on a PC. The MRG1502 is available for shipping to early customers.The Advance Release does not have FDA regulatory clearance. It is suitable for application evaluation and research work.
23 July 2012 - Cubresa has moved to larger offices. Our new address is Suite 3 1767 Portage Avenue, Winnipeg, Mb, Canada, R3J 0E7, which is at the corner of Portage and Berry.
17 July 2012 - Cubresa will be at RSNA 2012 November 25-30 in Chicago, Booth 4648. We look forward to seeing you there.
MR/Gamma Phantom Test Results
30 May 2012 - Cubresa has completed a first round of testing showing MR/Gamma hybrid imaging capability with a resulting co-registered image. This testing occurred in Winnipeg at the NRC-IBD facility, using the Siemens 3T Trio. The testing used a NORAS patient rest system, and a breast biopsy immobilization system which held a phantom in the same position for both the MRI and gamma imaging. The phantom was provided by NORAS MRI Products. The gamma image was taken in the fringe field of the magnet within minutes of the MRI image sequence. The compact gamma camera, only 15X15mm on the front face, was inserted into the square grid. The location for the gamma camera is chosen in the same way as a needle block location is chosen. Please contact James Schellenberg, CEO of Cubresa, at email@example.com if you have an interest in discussing these test results.
John Saunders added to Cubresa Technical Advisory Board.
1 May 2012 - Cubresa is pleased to announce that John Saunders, Ph.D., Founder of Innovative Magnetic Resonance Imaging Systems and former CSO of IMRIS, has joined our Technical Advisory Board. We look forward to working with John again, and are certain of his contribution to improve breast care through better imaging. John joins Andrew Goertzen, Ph.D., MRRCP and James Schellenberg, Ph.D., Cubresa Founder and CEO, on the Technical Advisory Board.